Onconova Therapeutics Price on December 11, 2024
ONTXDelisted Stock | USD 1.02 0.04 3.77% |
If you're considering investing in Onconova Stock, it is important to understand the factors that can impact its price. As of today, the current price of Onconova Therapeutics stands at 1.02, as last reported on the 12th of December 2024, with the highest price reaching 1.07 and the lowest price hitting 1.01 during the day. We have found twenty-nine technical indicators for Onconova Therapeutics, which you can use to evaluate the volatility of the company. Please check Onconova Therapeutics' Coefficient Of Variation of 1047.88, semi deviation of 4.35, and Risk Adjusted Performance of 0.0785 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Onconova Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Onconova |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ONTX |
Based on monthly moving average Onconova Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Onconova Therapeutics by adding Onconova Therapeutics to a well-diversified portfolio.
Related Headline
Ocugen Headline on 11th of December 2024
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease ... by gurufocus.com
MALVERN, Pa., Dec. 11, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and
Onconova Therapeutics Valuation on December 11, 2024
It is possible to determine the worth of Onconova Therapeutics on a given historical date. On December 11, 2024 Onconova was worth 1.06 at the beginning of the trading date compared to the closed value of 1.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Onconova Therapeutics stock. Still, in general, we apply an absolute valuation method to find Onconova Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Onconova Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Onconova Therapeutics' related companies.
Open | High | Low | Close | Volume | |
12/12/2024 | 1.06 | 1.07 | 1.01 | 1.02 | 0.00 |
Backtest Onconova Therapeutics | | | Onconova Therapeutics History | | | Onconova Therapeutics Valuation |
Onconova Therapeutics Trading Date Momentum on December 11, 2024
Onconova Therapeutics Fundamentals Correlations and Trends
By evaluating Onconova Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Onconova Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Onconova financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Onconova Therapeutics Stock history
Onconova Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Onconova is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Onconova Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Onconova Therapeutics stock prices may prove useful in developing a viable investing in Onconova Therapeutics
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Onconova Therapeutics Stock Technical Analysis
Onconova Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Onconova Therapeutics Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Onconova Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Onconova Therapeutics December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Onconova Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Onconova Therapeutics shares will generate the highest return on investment. By undertsting and applying Onconova Therapeutics stock market strength indicators, traders can identify Onconova Therapeutics entry and exit signals to maximize returns
Onconova Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Onconova Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Onconova Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Onconova to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0785 | |||
Jensen Alpha | 0.7229 | |||
Total Risk Alpha | (0.41) | |||
Sortino Ratio | 0.1541 | |||
Treynor Ratio | 0.7295 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |